aluates Reports

$ 0.0

Automative

Global Varicella Vaccine Market Research Report 2026

Published Date: 2026-01-30

Report Code: QYRE-Auto-37D11956

Global Varicella Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028

BUY CHAPTERS

Global Varicella Vaccine Market Research Report 2026

Code: QYRE-Auto-37D11956

Report

2026-01-30

Pages:114

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

GSK

Shanghai Institute

BCHT

Changsheng

Keygen

Green Cross

Biken

Varicella Vaccine Market Size

The global Varicella Vaccine market was valued at US$ 5185 million in 2025 and is anticipated to reach US$ 8708 million by 2032, at a CAGR of 7.8% from 2026 to 2032.

Varicella Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Varicella Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin

Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.

Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.

In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.

This report delivers a comprehensive overview of the global Varicella Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Varicella Vaccine. The Varicella Vaccine market size, estimates, and forecasts are provided in terms of sales volume (M Doses) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Varicella Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Varicella Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Varicella Vaccine Market Report

Report Metric	Details
Report Name	Varicella Vaccine Market
Accounted market size in 2025	US$ 5185 million
Forecasted market size in 2032	US$ 8708 million
CAGR	7.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Injection Freeze-Dried Powder
by Application	Kids Injection Adults Injection
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Varicella Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Varicella Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Varicella Vaccine Market growing?

Ans: The Varicella Vaccine Market witnessing a CAGR of 7.8% during the forecast period 2026-2032.

What is the Varicella Vaccine Market size in 2032?

Ans: The Varicella Vaccine Market size in 2032 will be US$ 8708 million.

What is the Varicella Vaccine Market share by type?

Ans: In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%.

Who are the main players in the Varicella Vaccine Market report?

Ans: The main players in the Varicella Vaccine Market are Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken

What are the Application segmentation covered in the Varicella Vaccine Market report?

Ans: The Applications covered in the Varicella Vaccine Market report are Kids Injection, Adults Injection

What are the Type segmentation covered in the Varicella Vaccine Market report?

Ans: The Types covered in the Varicella Vaccine Market report are Injection, Freeze-Dried Powder

1 Varicella Vaccine Market Overview

1.1 Product Definition

1.2 Varicella Vaccine by Type

1.2.1 Global Varicella Vaccine Market Value by Type: 2025 vs 2032

1.2.2 Injection

1.2.3 Freeze-Dried Powder

1.3 Varicella Vaccine by Application

1.3.1 Global Varicella Vaccine Market Value by Application: 2025 vs 2032

1.3.2 Kids Injection

1.3.3 Adults Injection

1.4 Global Varicella Vaccine Market Size Estimates and Forecasts

1.4.1 Global Varicella Vaccine Revenue 2021–2032

1.4.2 Global Varicella Vaccine Sales 2021–2032

1.4.3 Global Varicella Vaccine Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Varicella Vaccine Market Competition by Manufacturers

2.1 Global Varicella Vaccine Sales Market Share by Manufacturers (2021–2026)

2.2 Global Varicella Vaccine Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Varicella Vaccine Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Varicella Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Varicella Vaccine, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Varicella Vaccine, Product Types and Applications

2.7 Global Key Manufacturers of Varicella Vaccine, Date of Entry into the Industry

2.8 Global Varicella Vaccine Market Competitive Situation and Trends

2.8.1 Global Varicella Vaccine Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Varicella Vaccine Players Market Share by Revenue

2.8.3 Global Varicella Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Varicella Vaccine Market Scenario by Region

3.1 Global Varicella Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Varicella Vaccine Sales by Region: 2021–2032

3.2.1 Global Varicella Vaccine Sales by Region: 2021–2026

3.2.2 Global Varicella Vaccine Sales by Region: 2027–2032

3.3 Global Varicella Vaccine Revenue by Region: 2021–2032

3.3.1 Global Varicella Vaccine Revenue by Region: 2021–2026

3.3.2 Global Varicella Vaccine Revenue by Region: 2027–2032

3.4 North America Varicella Vaccine Market Facts & Figures by Country

3.4.1 North America Varicella Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Varicella Vaccine Sales by Country (2021–2032)

3.4.3 North America Varicella Vaccine Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Varicella Vaccine Market Facts & Figures by Country

3.5.1 Europe Varicella Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Varicella Vaccine Sales by Country (2021–2032)

3.5.3 Europe Varicella Vaccine Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Varicella Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Varicella Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Varicella Vaccine Sales by Region (2021–2032)

3.6.3 Asia Pacific Varicella Vaccine Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Varicella Vaccine Market Facts & Figures by Country

3.7.1 Latin America Varicella Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Varicella Vaccine Sales by Country (2021–2032)

3.7.3 Latin America Varicella Vaccine Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Varicella Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Varicella Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Varicella Vaccine Sales by Country (2021–2032)

3.8.3 Middle East and Africa Varicella Vaccine Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Varicella Vaccine Sales by Type (2021–2032)

4.1.1 Global Varicella Vaccine Sales by Type (2021–2026)

4.1.2 Global Varicella Vaccine Sales by Type (2027–2032)

4.1.3 Global Varicella Vaccine Sales Market Share by Type (2021–2032)

4.2 Global Varicella Vaccine Revenue by Type (2021–2032)

4.2.1 Global Varicella Vaccine Revenue by Type (2021–2026)

4.2.2 Global Varicella Vaccine Revenue by Type (2027–2032)

4.2.3 Global Varicella Vaccine Revenue Market Share by Type (2021–2032)

4.3 Global Varicella Vaccine Price by Type (2021–2032)

5 Segment by Application

5.1 Global Varicella Vaccine Sales by Application (2021–2032)

5.1.1 Global Varicella Vaccine Sales by Application (2021–2026)

5.1.2 Global Varicella Vaccine Sales by Application (2027–2032)

5.1.3 Global Varicella Vaccine Sales Market Share by Application (2021–2032)

5.2 Global Varicella Vaccine Revenue by Application (2021–2032)

5.2.1 Global Varicella Vaccine Revenue by Application (2021–2026)

5.2.2 Global Varicella Vaccine Revenue by Application (2027–2032)

5.2.3 Global Varicella Vaccine Revenue Market Share by Application (2021–2032)

5.3 Global Varicella Vaccine Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Varicella Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Merck Varicella Vaccine Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Varicella Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 GSK Varicella Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Shanghai Institute

6.3.1 Shanghai Institute Company Information

6.3.2 Shanghai Institute Description and Business Overview

6.3.3 Shanghai Institute Varicella Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Shanghai Institute Varicella Vaccine Product Portfolio

6.3.5 Shanghai Institute Recent Developments/Updates

6.4 BCHT

6.4.1 BCHT Company Information

6.4.2 BCHT Description and Business Overview

6.4.3 BCHT Varicella Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 BCHT Varicella Vaccine Product Portfolio

6.4.5 BCHT Recent Developments/Updates

6.5 Changsheng

6.5.1 Changsheng Company Information

6.5.2 Changsheng Description and Business Overview

6.5.3 Changsheng Varicella Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Changsheng Varicella Vaccine Product Portfolio

6.5.5 Changsheng Recent Developments/Updates

6.6 Keygen

6.6.1 Keygen Company Information

6.6.2 Keygen Description and Business Overview

6.6.3 Keygen Varicella Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Keygen Varicella Vaccine Product Portfolio

6.6.5 Keygen Recent Developments/Updates

6.7 Green Cross

6.7.1 Green Cross Company Information

6.7.2 Green Cross Description and Business Overview

6.7.3 Green Cross Varicella Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Green Cross Varicella Vaccine Product Portfolio

6.7.5 Green Cross Recent Developments/Updates

6.8 Biken

6.8.1 Biken Company Information

6.8.2 Biken Description and Business Overview

6.8.3 Biken Varicella Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Biken Varicella Vaccine Product Portfolio

6.8.5 Biken Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Varicella Vaccine Industry Chain Analysis

7.2 Varicella Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Varicella Vaccine Production Mode & Process Analysis

7.4 Varicella Vaccine Sales and Marketing

7.4.1 Varicella Vaccine Sales Channels

7.4.2 Varicella Vaccine Distributors

7.5 Varicella Vaccine Customer Analysis

8 Varicella Vaccine Market Dynamics

8.1 Varicella Vaccine Industry Trends

8.2 Varicella Vaccine Market Drivers

8.3 Varicella Vaccine Market Challenges

8.4 Varicella Vaccine Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck

GSK

Shanghai Institute

BCHT

Changsheng

Keygen

Green Cross

Biken

List of Tables

Table 1. Global Varicella Vaccine Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Varicella Vaccine Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Varicella Vaccine Market Competitive Situation by Manufacturers in 2025

Table 4. Global Varicella Vaccine Sales (M Doses) of Key Manufacturers (2021–2026)

Table 5. Global Varicella Vaccine Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Varicella Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Varicella Vaccine Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Varicella Vaccine Average Price (USD/Dose) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Varicella Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Varicella Vaccine, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Varicella Vaccine, Product Types and Applications

Table 12. Global Key Manufacturers of Varicella Vaccine, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Varicella Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Varicella Vaccine Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Varicella Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Varicella Vaccine Sales by Region (M Doses), 2021–2026

Table 18. Global Varicella Vaccine Sales Market Share by Region (2021–2026)

Table 19. Global Varicella Vaccine Sales by Region (M Doses), 2027–2032

Table 20. Global Varicella Vaccine Sales Market Share by Region (2027–2032)

Table 21. Global Varicella Vaccine Revenue by Region (US$ Million), 2021–2026

Table 22. Global Varicella Vaccine Revenue Market Share by Region (2021–2026)

Table 23. Global Varicella Vaccine Revenue by Region (US$ Million), 2027–2032

Table 24. Global Varicella Vaccine Revenue Market Share by Region (2027–2032)

Table 25. North America Varicella Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Varicella Vaccine Sales by Country (M Doses), 2021–2026

Table 27. North America Varicella Vaccine Sales by Country (M Doses), 2027–2032

Table 28. North America Varicella Vaccine Revenue by Country (US$ Million), 2021–2026

Table 29. North America Varicella Vaccine Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Varicella Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Varicella Vaccine Sales by Country (M Doses), 2021–2026

Table 32. Europe Varicella Vaccine Sales by Country (M Doses), 2027–2032

Table 33. Europe Varicella Vaccine Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Varicella Vaccine Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Varicella Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Varicella Vaccine Sales by Region (M Doses), 2021–2026

Table 37. Asia Pacific Varicella Vaccine Sales by Region (M Doses), 2027–2032

Table 38. Asia Pacific Varicella Vaccine Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Varicella Vaccine Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Varicella Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Varicella Vaccine Sales by Country (M Doses), 2021–2026

Table 42. Latin America Varicella Vaccine Sales by Country (M Doses), 2027–2032

Table 43. Latin America Varicella Vaccine Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Varicella Vaccine Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Varicella Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Varicella Vaccine Sales by Country (M Doses), 2021–2026

Table 47. Middle East and Africa Varicella Vaccine Sales by Country (M Doses), 2027–2032

Table 48. Middle East and Africa Varicella Vaccine Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Varicella Vaccine Revenue by Country (US$ Million), 2027–2032

Table 50. Global Varicella Vaccine Sales (M Doses) by Type (2021–2026)

Table 51. Global Varicella Vaccine Sales (M Doses) by Type (2027–2032)

Table 52. Global Varicella Vaccine Sales Market Share by Type (2021–2026)

Table 53. Global Varicella Vaccine Sales Market Share by Type (2027–2032)

Table 54. Global Varicella Vaccine Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Varicella Vaccine Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Varicella Vaccine Revenue Market Share by Type (2021–2026)

Table 57. Global Varicella Vaccine Revenue Market Share by Type (2027–2032)

Table 58. Global Varicella Vaccine Price (USD/Dose) by Type (2021–2026)

Table 59. Global Varicella Vaccine Price (USD/Dose) by Type (2027–2032)

Table 60. Global Varicella Vaccine Sales (M Doses) by Application (2021–2026)

Table 61. Global Varicella Vaccine Sales (M Doses) by Application (2027–2032)

Table 62. Global Varicella Vaccine Sales Market Share by Application (2021–2026)

Table 63. Global Varicella Vaccine Sales Market Share by Application (2027–2032)

Table 64. Global Varicella Vaccine Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Varicella Vaccine Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Varicella Vaccine Revenue Market Share by Application (2021–2026)

Table 67. Global Varicella Vaccine Revenue Market Share by Application (2027–2032)

Table 68. Global Varicella Vaccine Price (USD/Dose) by Application (2021–2026)

Table 69. Global Varicella Vaccine Price (USD/Dose) by Application (2027–2032)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 73. Merck Varicella Vaccine Product

Table 74. Merck Recent Developments/Updates

Table 75. GSK Company Information

Table 76. GSK Description and Business Overview

Table 77. GSK Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 78. GSK Varicella Vaccine Product

Table 79. GSK Recent Developments/Updates

Table 80. Shanghai Institute Company Information

Table 81. Shanghai Institute Description and Business Overview

Table 82. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 83. Shanghai Institute Varicella Vaccine Product

Table 84. Shanghai Institute Recent Developments/Updates

Table 85. BCHT Company Information

Table 86. BCHT Description and Business Overview

Table 87. BCHT Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 88. BCHT Varicella Vaccine Product

Table 89. BCHT Recent Developments/Updates

Table 90. Changsheng Company Information

Table 91. Changsheng Description and Business Overview

Table 92. Changsheng Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 93. Changsheng Varicella Vaccine Product

Table 94. Changsheng Recent Developments/Updates

Table 95. Keygen Company Information

Table 96. Keygen Description and Business Overview

Table 97. Keygen Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 98. Keygen Varicella Vaccine Product

Table 99. Keygen Recent Developments/Updates

Table 100. Green Cross Company Information

Table 101. Green Cross Description and Business Overview

Table 102. Green Cross Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 103. Green Cross Varicella Vaccine Product

Table 104. Green Cross Recent Developments/Updates

Table 105. Biken Company Information

Table 106. Biken Description and Business Overview

Table 107. Biken Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 108. Biken Varicella Vaccine Product

Table 109. Biken Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Varicella Vaccine Distributors List

Table 113. Varicella Vaccine Customers List

Table 114. Varicella Vaccine Market Trends

Table 115. Varicella Vaccine Market Drivers

Table 116. Varicella Vaccine Market Challenges

Table 117. Varicella Vaccine Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Varicella Vaccine

Figure 2. Global Varicella Vaccine Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Varicella Vaccine Market Share by Type: 2025 & 2032

Figure 4. Injection Product Picture

Figure 5. Freeze-Dried Powder Product Picture

Figure 6. Global Varicella Vaccine Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Varicella Vaccine Market Share by Application: 2025 & 2032

Figure 8. Kids Injection

Figure 9. Adults Injection

Figure 10. Global Varicella Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Varicella Vaccine Market Size (US$ Million), 2021–2032

Figure 12. Global Varicella Vaccine Sales (M Doses), 2021–2032

Figure 13. Global Varicella Vaccine Average Price (USD/Dose), 2021–2032

Figure 14. Varicella Vaccine Report Years Considered

Figure 15. Varicella Vaccine Sales Share by Manufacturers in 2025

Figure 16. Global Varicella Vaccine Revenue Share by Manufacturers in 2025

Figure 17. Top 5 and Top 10 Global Varicella Vaccine Players: Market Share by Revenue in Varicella Vaccine in 2025

Figure 18. Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 19. Global Varicella Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 20. North America Varicella Vaccine Sales Market Share by Country (2021–2032)

Figure 21. North America Varicella Vaccine Revenue Market Share by Country (2021–2032)

Figure 22. U.S. Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 23. Canada Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Europe Varicella Vaccine Sales Market Share by Country (2021–2032)

Figure 25. Europe Varicella Vaccine Revenue Market Share by Country (2021–2032)

Figure 26. Germany Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. France Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. U.K. Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Italy Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Russia Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Asia Pacific Varicella Vaccine Sales Market Share by Region (2021–2032)

Figure 32. Asia Pacific Varicella Vaccine Revenue Market Share by Region (2021–2032)

Figure 33. China Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Japan Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. South Korea Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. India Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Australia Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. China Taiwan Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Indonesia Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Thailand Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Malaysia Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Latin America Varicella Vaccine Sales Market Share by Country (2021–2032)

Figure 43. Latin America Varicella Vaccine Revenue Market Share by Country (2021–2032)

Figure 44. Mexico Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Brazil Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Argentina Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Middle East and Africa Varicella Vaccine Sales Market Share by Country (2021–2032)

Figure 48. Middle East and Africa Varicella Vaccine Revenue Market Share by Country (2021–2032)

Figure 49. Turkey Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Saudi Arabia Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. UAE Varicella Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Global Sales Market Share of Varicella Vaccine by Type (2021–2032)

Figure 53. Global Revenue Market Share of Varicella Vaccine by Type (2021–2032)

Figure 54. Global Varicella Vaccine Price (USD/Dose) by Type (2021–2032)

Figure 55. Global Sales Market Share of Varicella Vaccine by Application (2021–2032)

Figure 56. Global Revenue Market Share of Varicella Vaccine by Application (2021–2032)

Figure 57. Global Varicella Vaccine Price (USD/Dose) by Application (2021–2032)

Figure 58. Varicella Vaccine Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Chickenpox Varicella Vaccine Market

Global Avian Pox Vaccine Market Research Report 2024

Global Poultry Vaccines Market Research Report 2025

Global Varicella Vaccination Market Research Report 2025

Chickenpox Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Varicella Live Vaccine Market Insights Forecast to 2030

Varicella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Varicella Virus Attenuated Live Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Live Attenuated Varicella Vaccine Market Research Report 2025

Global Varicella Attenuated Live Vaccination Market Research Report 2025

Global Varicella Attenuated Live Vaccine Market Research Report 2025

Global Monkeypox Vaccine Market Research Report 2025

Global Live Herpes Zoster Vaccine Market Research Report 2024

Global Live Attenuated Vaccine for Chickenpox Market Research Report 2025

Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Monkeypox Virus Vaccine Market Research Report 2024

Human Varicella Zoster Immunoglobulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Measles Mumps Rubella and Varicella Combined Vaccine Market Research Report 2024

Global Herpes Simplex Virus HSV Vaccines Market Insights Forecast to 2030

Global Flu Vaccination Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions